AnPac Bio-Medical Science Co Ltd - ADR

NASDAQ:ANPC  
3.83
-0.34 (-8.15%)
Other Pre-Announcement

AnPac Bio-Medical Science Co Ltd Pre-Announced It Has Experienced Strong Growth In Test Volume In First Half Year Of 2021

Published: 07/20/2021 12:40 GMT
AnPac Bio-Medical Science Co Ltd - ADR (ANPC) - Anpac Bio-medical Science Co Ltd - Pre-announced It Has Experienced Strong Growth in Test Volume in First Half Year of 2021.
Anpac Bio-medical Science Co Ltd - Total Number of Paid Customers and Testing Volume in H1 2021 Up Almost 110%.
Anpac Bio-medical Science - in Q2, Total Paid Tests and Paid Cancer Tests Up About 280%, About 270%, Respectively (quarter Over Quarter).
Anpac Bio-medical Science Co Ltd - Expects That Strong Test Volume Growth Will Continue Throughout This Year.